Home / Business News (page 2)

Business News

Medtronic Enters into Definitive Agreement to Acquire Titan Spine

DUBLIN – May 9, 2019 – Medtronic plc (NYSE:MDT), a global leader in medical technology, today announced that it has entered into a definitive agreement pursuant to which it will acquire Titan Spine, a privately-held titanium spine interbody implant and surface technology company. The boards of directors of both companies have …

Read More »

Boston Scientific to Acquire Vertiflex, Expanding Portfolio of Interventional Pain Therapies

MARLBOROUGH, Mass., May 9, 2019 /PRNewswire/ — Boston Scientific (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Vertiflex, Inc., a privately-held company which has developed and commercialized the Superion® Indirect Decompression System, a minimally-invasive device used to improve physical function and reduce pain in …

Read More »

Takeda Simplifies Portfolio through Sales of Xiidra to Novartis for up to $5.3 Billion and TachoSil to Ethicon for Approximately $400 Million

OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into agreements to divest its Xiidra® (lifitegrast ophthalmic solution) 5% product (“Xiidra®”) to Novartis and its TachoSil® Fibrin Sealant Patch (“TachoSil®”) to Ethicon as part of its strategy to focus on business areas core to its long-term growth and …

Read More »

Premier Selling its Specialty Pharmacy Business to CVS Health Unit

CHARLOTTE, N.C. — Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, is exiting its specialty pharmacy business to enhance the company’s focus on the continuing evolution of its core supply chain, enterprise analytics and performance improvement capabilities. On May 6, 2019, certain of Premier’s consolidated subsidiaries entered into a definitive …

Read More »

Pfizer Acquires Clinical-Stage Biotech Therachon for up to $810 Million, Expanding Rare Disease Pipeline

NEW YORK & BASEL, Switzerland–(BUSINESS WIRE)–Pfizer (NYSE: PFE) today announced that it has entered into a definitive agreement to acquire all the shares of Therachon Holding AG, a privately-held clinical-stage biotechnology company focused on rare diseases, with assets in development for the treatment of achondroplasia and short bowel syndrome (SBS). Under …

Read More »

Gilead Sciences and Goldfinch Bio Enter Strategic Collaboration for Development of Novel Therapies for Kidney Disease

FOSTER CITY, Calif. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) and Goldfinch Bio, Inc., a biotechnology company focused on developing precision therapies for patients with kidney diseases, today announced a strategic collaboration to discover, develop and commercialize a pipeline of innovative therapeutics for diabetic kidney disease (DKD) and certain orphan kidney …

Read More »

Sensei Biotherapeutics and AstraZeneca Enter Clinical Trial Collaboration Evaluating the Combination of SNS-301 and Imfinzi

GAITHERSBURG, Md.–(BUSINESS WIRE)–Sensei Biotherapeutics, Inc., a clinical-stage biopharmaceutical company developing precision immuno-oncology therapies, today announced a clinical trial collaboration with AstraZeneca to evaluate the safety, tolerability and preliminary activity of AstraZeneca’s IMFINZI® (durvalumab), a human monoclonal antibody directed against programmed death-ligand 1 (PD-L1), in combination with SNS-301. SNS-301, Sensei’s first-in-class …

Read More »

Takeda and Skyhawk Partner for Development of Novel Small Molecule RNA Splicing Modifiers for Neurodegenerative Diseases

WALTHAM, Mass., May 6, 2019 /PRNewswire/ — Skyhawk Therapeutics, Inc. (Skyhawk) today announced a strategic collaboration with Takeda Pharmaceutical Company Limited (Takeda) in which Skyhawk will use its SkySTAR™ technology platform to discover and pre-clinically develop innovative small molecule treatments directed to certain neurological disease targets. The agreement grants Takeda …

Read More »

Roche Expands Partnership with Bio-Techne to Offer Drug Discovery Researchers New Chromogenic Detection Options for mRNA ISH Tissue Analysis

INDIANAPOLIS, May 6, 2019 /PRNewswire/ — Roche (SIX: RO, ROG;OTCQX: RHHBY) today announced it has expanded its partnership with Bio-Techne by offering drug discovery researchers in the U.S. new chromogenic detection kits for automated in situ hybridization (ISH) tissue analysis. The new Roche kits include the DISCOVERY mRNA Purple HRP …

Read More »

Lundbeck to Acquire Abide Therapeutics, Adding a Unique Discovery Platform and Tourette’s Program

Valby, Denmark, San Diego, USA, 6 May 2019 – H. Lundbeck A/S (Lundbeck) and Abide Therapeutics, Inc. (Abide) today announced signing of a definitive agreement in which Lundbeck LLC has agreed to acquire Abide. Under the terms of the agreement, Lundbeck may pay USD 250 million (approximately DKK 1.65 billion) upfront …

Read More »